A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD

被引:2
作者
Thakral, Nimish [1 ]
Desalegn, Hailemichael [2 ]
Diaz, Luis Antonio [3 ]
Cabrera, Daniel [4 ,5 ]
Loomba, Rohit [6 ]
Arrese, Marco [3 ]
Arab, Juan Pablo [3 ,7 ]
机构
[1] Univ Kentucky, Div Gastroenterol & Hepatol, Lexington, KY USA
[2] Western Univ, Schulich Sch Med, Dept Med, Div Gastroenterol, London, ON, Canada
[3] Pontificia Univ Catolica Chile, Escuela Med, Dept Gastroenterol, Santiago, Chile
[4] Univ los Andes, Ctr Invest & Innovac Biomed CiiB, Santiago, Chile
[5] Univ Bernardo OHiggins, Escuela Med, Fac Ciencias Med, Santiago, Chile
[6] Univ Calif San Diego, MASLD Res Ctr, Div Gastroenterol & Hepatol, San Diego, CA USA
[7] Virginia Commonwealth Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Internal Med, Richmond, VA 23284 USA
关键词
biomarkers; steatosis; MASLD; cirrhosis; precision medicine; FATTY LIVER-DISEASE; MAGNETIC-RESONANCE ELASTOGRAPHY; PREDICTING FIBROSIS STAGE; TRANSIENT ELASTOGRAPHY; NONALCOHOLIC STEATOHEPATITIS; DIAGNOSTIC-ACCURACY; NONINVASIVE DIFFERENTIATION; UNITED-STATES; STEATOSIS; MARKERS;
D O I
10.1055/a-2364-2928
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The new nomenclature of metabolic dysfunction-associated steatotic liver disease (MASLD) emphasizes a positive diagnosis based on cardiometabolic risk factors. This definition is not only less stigmatizing but also allows for subclassification and stratification, thereby addressing the heterogeneity of what was historically referred to as nonalcoholic fatty liver disease. The heterogeneity within this spectrum is influenced by several factors which include but are not limited to demographic/dietary factors, the amount of alcohol use and drinking patterns, metabolic status, gut microbiome, genetic predisposition together with epigenetic factors. The net effect of this dynamic and intricate system-level interaction is reflected in the phenotypic presentation of MASLD. Therefore, the application of precision medicine in this scenario aims at complex phenotyping with consequent individual risk prediction, development of individualized preventive strategies, and improvements in the clinical trial designs. In this review, we aim to highlight the importance of precision medicine approaches in MASLD, including the use of novel biomarkers of disease, and its subsequent utilization in future study designs.
引用
收藏
页码:273 / 286
页数:14
相关论文
共 125 条
[1]   Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease [J].
Adams, Leon A. ;
George, Jacob ;
Bugianesi, Elisabetta ;
Rossi, Enrico ;
De Boer, W. Bastiaan ;
van der Poorten, David ;
Ching, Helena L. I. ;
Bulsara, Max ;
Jeffrey, Gary P. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (10) :1536-1543
[2]   Liver Transplantation for Nonalcoholic Steatohepatitis The New Epidemic [J].
Agopian, Vatche G. ;
Kaldas, Fady M. ;
Hong, Johnny C. ;
Whittaker, Meredith ;
Holt, Curtis ;
Rana, Abbas ;
Zarrinpar, Ali ;
Petrowsky, Henrik ;
Farmer, Douglas ;
Yersiz, Hasan ;
Xia, Victor ;
Hiatt, Jonathan R. ;
Busuttil, Ronald W. .
ANNALS OF SURGERY, 2012, 256 (04) :624-633
[3]   Novel Plasma Biomarkers Associated With Liver Disease Severity in Adults With Nonalcoholic Fatty Liver Disease [J].
Ajmera, Veeral ;
Perito, Emily R. ;
Bass, Nathan M. ;
Terrault, Norah A. ;
Yates, Katherine P. ;
Gill, Ryan ;
Loomba, Rohit ;
Diehl, Anna Mae ;
Aouizerat, Bradley E. .
HEPATOLOGY, 2017, 65 (01) :65-77
[4]   OxNASH Score Correlates with Histologic Features and Severity of Nonalcoholic Fatty Liver Disease [J].
Alkhouri, Naim ;
Berk, Michael ;
Yerian, Lisa ;
Lopez, Rocio ;
Chung, Yoon-Mi ;
Zhang, Renliang ;
McIntyre, Thomas M. ;
Feldstein, Ariel E. ;
Hazen, Stanley L. .
DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (07) :1617-1624
[5]   Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis [J].
Ampuero, Javier ;
Pais, Raluca ;
Aller, Rocio ;
Gallego-Duran, Rocio ;
Crespo, Javier ;
Garcia-Monzon, Carmelo ;
Boursier, Jerome ;
Vilar, Eduardo ;
Petta, Salvatore ;
Zheng, Ming-Hua ;
Escudero, Desamparados ;
Luis Calleja, Jose ;
Aspichueta, Patricia ;
Diago, Moises ;
Miguel Rosales, Jose ;
Caballeria, Joan ;
Gomez-Camarero, Judith ;
Lo Iacono, Oreste ;
Benlloch, Salvador ;
Albillos, Agustin ;
Turnes, Juan ;
Banales, Jesus M. ;
Ratziu, Vlad ;
Romero-Gomez, Manuel ;
Agustin, Salvador ;
Jorquera, Francisco ;
Frances, Ruben ;
Garcia-Samaniego, Javier ;
Salmeron, Javier ;
Fernandez-Rodriguez, Conrado ;
Estevez, Pamela ;
Andrade, Raul ;
Soriano, German ;
Fernandez-Bermejo, Miguel ;
Arias Loste, Maria Teresa ;
Siguenza, Rebeca ;
Giannetti, Aurora ;
del Pozo Maroto, Elvira .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) :216-+
[6]  
[Anonymous], 2000, HUMAN GROWTH HORMONE, DOI [10.1007/978-1-59259-015-5, DOI 10.1007/978-1-59259-015-5]
[7]   Impact of non-invasive biomarkers on hepatology practice: Past, present and future [J].
Anstee, Quentin M. ;
Castera, Laurent ;
Loomba, Rohit .
JOURNAL OF HEPATOLOGY, 2022, 76 (06) :1362-1378
[8]   Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials [J].
Anstee, Quentin M. ;
Lawitz, Eric J. ;
Alkhouri, Naim ;
Wong, Vincent Wai-Sun ;
Romero-Gomez, Manuel ;
Okanoue, Takeshi ;
Trauner, Michael ;
Kersey, Kathryn ;
Li, Georgia ;
Han, Ling ;
Jia, Catherine ;
Wang, Lulu ;
Chen, Guang ;
Subramanian, G. Mani ;
Myers, Robert P. ;
Djedjos, C. Stephen ;
Kohli, Anita ;
Bzowej, Natalie ;
Younes, Ziad ;
Sarin, Shiv ;
Shiffman, Mitchell L. ;
Harrison, Stephen A. ;
Afdhal, Nezam H. ;
Goodman, Zachary ;
Younossi, Zobair M. .
HEPATOLOGY, 2019, 70 (05) :1521-1530
[9]   Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease [J].
Asanuma, Taketoshi ;
Ono, Masafumi ;
Kubota, Kei ;
Hirose, Akira ;
Hayashi, Yoshihiro ;
Saibara, Toshiji ;
Inanami, Osamu ;
Ogawa, Yasuhiro ;
Enzan, Hideaki ;
Onishi, Saburo ;
Kuwabara, Mikinori ;
Oben, Jude A. .
GUT, 2010, 59 (02) :258-266
[10]   NASH Is the Most Rapidly Growing Etiology for Acute-on-Chronic Liver Failure-Related Hospitalization and Disease Burden in the United States: A Population-Based Study [J].
Axley, Page ;
Ahmed, Zunirah ;
Arora, Sumant ;
Haas, Allen ;
Kuo, Yong-Fang ;
Kamath, Patrick S. ;
Singal, Ashwani K. .
LIVER TRANSPLANTATION, 2019, 25 (05) :695-705